Labs / Assays & in vitro testing

GlyTech, Inc.
Kyoto, Japan · glytech-inc.com
GMP
GlyTech, Inc. develops glycan production and chemical glycosylation technologies for drug discovery, biopharmaceutical development, and oligonucleotide therapeutics. It serves research and development partners, the biopharmaceutical industry, and the life science community from offices in Kyoto and a laboratory in Sendai, Japan.
Their website has a general contact form; we send your quote request through it.
What they offer
Drug discovery and development
Supports drug development projects using glycan production and chemical glycosylation technologies.
Lead discovery using scaffold peptide backbones
Discovers peptide leads using natural scaffold peptides and an in vitro evolution screening platform.
Lead modification using glycans
Designs and controls glycan position, structure, and number on target compounds by chemical glycosylation.
Custom glycan synthesis
Synthesizes custom glycans and glycan derivatives for specific research, development, and manufacturing needs.
Custom glycopeptide synthesis
Synthesizes homogeneous glycopeptides and glycoproteins with controlled glycoforms.
Glycosylation service
Chemically glycosylates expressed proteins and other materials.
Contract API manufacturing
Provides contract manufacturing of glycopeptides and glycoproteins on a commercialization scale.
Physico-chemical characterization
Offers analysis services for physico-chemical characterization.
Structural characterization
Offers analysis services for structural characterization.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, Peptide, Oligonucleotide
- Species and models
- human-type glycans, animal cells, cDNA screening system
- Assays and studies
- HPLC, MS
- Scale and capacity
- research to production scale, minimum order 1.0 mg, up to kilogram-scale glycan intermediate production, milligram to gram scale, commercialization scale
- Therapeutic areas
- drug discovery, biopharmaceuticals, oligonucleotide therapeutics, biomarker discovery, antibody development, DDS research, infection, inflammation, cancer
- Turnaround
- 2 to 3 months · a further 3 to 4 months
- What to send
- target and initial criteria · project needs for custom synthesis
- Minimums and prices
- minimum order 1.0 mg
- Sites
- Kyoto, Japan · Sendai, Japan
- Quality
- HPLC and MS analysis (quality confirmation for synthesized glycopeptides/glycoproteins)
- Founded
- 2012
Similar labs. Aurigene Pharmaceutical Services, Sparx BIO, Bioneeds, CDI Labs
Found in a contract services directory. Listing built from glytech-inc.com. Work here? Claim this listing.